Advertisement
Table 2 Prevalence OR# of musculoskeletal complaints (MSCs) related to DM and non-fasting glucose levels
| Variables | Total | Chronic MSCs | Chronic widespread MSCs MSCs | Chronic non-widespread MSCs | |||
|---|---|---|---|---|---|---|---|
| 64,785 | % | OR (CI) | % | OR (CI) | % | OR (CI) | |
| DM | |||||||
| No | 62,629 | 46.2 | 1.0 (reference) | 5.0 | 1.0 (reference) | 41.3 | 1.0 (reference) |
| Yes | 1,940 | 56.9 | 1.2 (1.1–1.3) | 5.9 | 1.3 (1.1–1.6) | 51.0 | 1.1 (1.0–1.3) |
| No, but glucose ≥ 11.1 | 216 | 45.4 | 0.7 (0.5–0.9) | 5.1 | 0.8 (0.4–1.5) | 40.3 | 0.7 (0.5–0.9) |
| DM | |||||||
| No | 62,629 | 42.2 | 1.0 (reference) | 5.0 | 1.0 (reference) | 41.3 | 1.0 (reference) |
| Type 1 | 122 | 45.9 | 1.0 (0.7–1.5) | 3.3 | 0.7 (0.2–1.9) | 42.6 | 1.1 (0.7–1.6) |
| Type 2 | 1,120 | 57.7 | 1.1 (1.0–1.3) | 6.1 | 1.3 (1.0–1.7) | 51.6 | 1.1 (1.0–1.3) |
| LADA | 127 | 56.7 | 1.1 (0.8–1.6) | 5.5 | 1.2 (0.5–2.6) | 51.2 | 1.2 (0.8–1.7) |
| Unclassified | 571 | 57.8 | 1.2 (1.0–1.5) | 6.3 | 1.6 (1.1–2.3) | 51.5 | 1.2 (1.0–1.4) |
| No, but glucose ≥ 11.1 | 216 | 45.4 | 0.7 (0.5–0.9) | 5.1 | 0.8 (0.4–1.5) | 40.3 | 0.7 (0.5–0.9) |
| Serum glucose | |||||||
| ≤ 4.7 mmol/l | 16,198 | 43.2 | 1.0 (reference) | 4.8 | 1.0 (reference) | 38.3 | 1.0 (reference) |
| 4.8–5.2 mmol/l | 19,151 | 46.7 | 1.0 (0.9–1.0) | 5.2 | 1.0 (0.9–1.1) | 41.4 | 1.0 (0.9–1.0) |
| 5.3–5.8 mmol/l | 14,737 | 47.9 | 0.9 (0.9–1.0) | 5.1 | 0.9 (0.8–1.0) | 42.8 | 0.9 (0.9–1.0) |
| ≥ 5.9 mmol/l | 14,316 | 49.1 | 0.9 (0.8–0.9) | 5.0 | 0.8 (0.7–0.9) | 44.2 | 0.9 (0.8–0.9) |
| Missing | 383 | 36.6 | 0.6 (0.5–0.8) | 0.8 | 0.1 (0.0–0.4) | 35.8 | 0.6 (0.5–0.8) |
| P-trend value$ | < 0.001 | < 0.001 | < 0.001 | ||||
| P trend value$ (β) | < 0.001 (-,022) | 0.045 (-,026) | < 0.001 (-,021) | ||||
